跳到正文
原文
Nature 综合主刊· Guo Zhao·· 18 天前AI 评分31

中国应公开监管决策背后的动物实验替代证据

China should share the evidence behind animal-testing alternatives openly

AI 导读

中国PIONEER试点项目自9月启动,推广药物测试的新方法,如人体组织模型和计算机模拟,并计划公布验证方法、案例研究和技术要点。研究团队建议下一步应公开监管决策的证据,供公众审查。

正文
  • CORRESPONDENCE
  • 03 November 2026

By

  1. Guo Zhao
    1. Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

  2. Shuhang Wang
    1. Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

  3. Ning Li
    1. Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

China’s PIONEER pilot, implemented in September, promotes fresh approaches to drug testing, including human tissue models and computer simulations. It promises to publish lists of validated methods, case studies and key technical points. Its next step should be to make the evidence behind regulatory decisions open to scrutiny.

Nature 659, 264 (2026)

doi: https://doi.org/10.1038/d41586-026-03561-7

Competing Interests

The authors declare no competing interests.

Subjects

Latest on:

来源:Nature 综合主刊 · nature.com